The Psychology of Fraud, Episode 4: A Focus on the Human Side


In the final episode of this series, the experts share their conclusions and why examining the human side of fraud—in addition to the instruments of fraud—is key.

Why do individuals choose to commit fraud—and how are they able to get away with it? In this series, “The Psychology of Fraud,” the experts have discussed myths associated with fraud, some high-profile examples of fraud, and the impact of fraud in the C suite. In this final episode, the experts discuss the primary emotions involved in committing fraud and the role of antisocial personality disorders, as well as the importance of studying the human side of fraud in addition to the economic consequences.

See “The Psychology of Fraud, Episode 1: Myths and Misconceptions” here.

See “The Psychology of Fraud, Episode 2: The Shark, the Lark, and the Mark: Why Do People Commit Fraud?” here.

See “The Psychology of Fraud, Episode 3: Big Challenges of Fraud in the C Suite” here.

Mr Bigelow is president of The Bigelow Consulting Group, Inc. He also functions as the vice president—strategy, marketing, and communications for The Behavioral Forensics Group™ LLC, a consulting firm that treats fraud as a human act and explores the psychology of fraud.

Dr Morrison is a clinical assistant professor of psychiatry at Rosalind Franklin University’s Chicago School of Medicine, and past president of the Academy of Organizational and Occupational Psychiatry. He is also a member of the Group for the Advancement of Psychiatry (GAP)–Committee on Work & Organizations; Institute for Fraud Prevention (IFP); Tomkins Institute of Applied Studies of Motivation, Emotion and Cognition. He is a co-author of A.B.C.’s of Behavioral Forensics and Psychiatry of Workplace Dysfunction, and a regular contributor to the B4G™ blog,

Dr Ramamoorti is currently an associate professor of accounting at the University of Dayton and the managing principal and CEO of The Behavioral Forensics Group™ LLC. He is also a regular contributor to the B4G™ blog,

Related Videos
“What we’re striving to do is conquer the unmet needs that are still here with treating ADHD, especially from a medication standpoint.”
Work takes up one-third of a patient’s life—it is important that we pay attention to it.
A new treatment in development is poised to be a game-changer for patients with postpartum depression.
An expert discusses the latest on EndeavorRx and more digital therapeutics for this patient population.
© 2024 MJH Life Sciences

All rights reserved.